Read twice and referred to the Committee on Veterans' Affairs.
The bill amends 38 U.S.C. §1311 to treat veterans who die from amyotrophic lateral sclerosis (ALS) as qualifying for increased dependency and indemnity compensation (DIC) for surviving spouses regardless of how long the veteran had ALS. The amendment applies to veterans who die from ALS on or after October 1, 2022.
Liberals emphasize equity and survivor relief benefits
Narrow veterans benefit expansion with low controversy, but requires floor time and approval of cost; modest resistance possible over spending.
The bill amends 38 U.S.C. §1311 to treat veterans who die from amyotrophic lateral sclerosis (ALS) as qualifying for increased dependency and indemnity compensation (DIC) for surviving spouses regardless of how long the veteran had ALS.
The amendment applies to veterans who die from ALS on or after October 1, 2022.
The change is limited to the DIC rate classification in section 1311(a)(2).
Narrow, sympathetic veterans-benefit expansion with limited fiscal exposure and bipartisan framing raises likelihood, pending cost scoring and congressional scheduling.
How solid the drafting looks.
Liberals emphasize equity and survivor relief benefits
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberals emphasize equity and survivor relief benefits
Likely strongly supportive.
The bill expands survivor benefits for veterans who die from ALS, addressing an equity gap for spouses.
Progressives will view this as targeted relief for a serious, service-connected-implicated disease.
Generally favorable if costs and implementation are clear.
The bill is targeted, limited in scope, and bipartisan, but requires fiscal and administrative clarity.
Centrists will weigh veterans' need against budgetary tradeoffs.
Cautious support for veterans but wary of unfunded benefit expansions.
Conservatives may approve targeted veteran benefits, but will press for fiscal offsets and strict verification to limit precedent.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow, sympathetic veterans-benefit expansion with limited fiscal exposure and bipartisan framing raises likelihood, pending cost scoring and congressional scheduling.
The bill has not accumulated any surfaced votes yet.
Liberals emphasize equity and survivor relief benefits
Narrow, sympathetic veterans-benefit expansion with limited fiscal exposure and bipartisan framing raises likelihood, pending cost scoring…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Justice for ALS Veterans Act of 2025.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.